REQUEST A DEMO
Total
USD $0.00
Search more companies

Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Ophthalmic Goods Manufacturing
Full name: Ocumension Therapeutics Profile Updated: February 26, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) is an enterprise based in China. Its main office is in Shanghai. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on April 01, 2026. The total number of employees is currently 101 - 500 (2025). From the latest financial highlights, Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) reported a net sales revenue increase of 75.41% in Q2C2025. There was a total growth of 28.78% in Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港))’s total assets over the same period. The net profit margin of Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) increased by 45.29% in 2025.

Headquarters
502-1 Want Want Plaza, 211 Shimen Yi Road, Jing'An District, Prc
Shanghai; Shanghai;

Contact Details: Purchase the Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) report to view the information.

Website: http://www.ocumension.com

Basic Information
Total Employees:
Purchase the Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) report to view the information.
Outstanding Shares:
Purchase the Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) report to view the information.
Registered Capital:
Purchase the Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) report to view the information.
Financial Auditors:
Purchase the Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) report to view the information.
Incorporation Date:
April 01, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
16.71%
Purchase this report to view the information.
14.4%
Purchase this report to view the information.
10.61%
Purchase this report to view the information.
9.39%
Purchase this report to view the information.
4.55%
Subsidiaries
Ocuarmor Medtech (United Kingdom)
100%
Ocuarmor Medtech (Hk) Limited (Hong Kong SAR, China)
100%
Ocumension Hong Kong (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
75.41%
Total Operating Revenue
74.85%
Operating Profit
17.84%
EBITDA
49.86%
Net Profit/Loss for the Period
12.57%
Total Assets
28.78%
Total Equity
31.95%
Operating Profit Margin
51.97%
Net Profit Margin
45.29%
Return on Equity (ROE)
1.85%
Debt / Equity
1724%
Quick Ratio
-140.82%
Cash Ratio
-1.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?